American Health Packaging has recalled one lot of Valsartan Tablets, USP, 160mg. The pills come in 100-count blisters with a lot number of 17971 and a March 2020 expiration date.
The medication’s manufacturer, Aurobindo Pharma USA, initiated the first recall of Valsartan in December 2018. The company later expanded the recall in March.
Recalls on blood pressure medications have been frequent. According to WUSA9, there have been three recalls on blood pressure medications within the last week and five within the last two weeks. There have been a total of 21 recalls since July 2018. In that time, the affected blood pressure meds have been found to contain traces of NDEA, N-Methylnitrosobutyric acid (NMBA), and N-Nitrosodimethylamine (NDMA).
The chemicals are thought to be impurities capable of increasing cancer risk in patients who take the blood pressure meds on a regular basis.
In an attempt to explain the possible reasons for contamination, the FDA claims that it might just be a consequence of specific chemical reactions during the manufacturing process.
As with previous recalls of blood pressure medication, the FDA recommends that patients continue to take the affected meds while consulting with a pharmacist and health care provider to find a proper alternative.
The following companies are affected by the Valsartan recall:
Thomas J. Henry Injury Attorneys are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of recalled medications or pharmaceuticals, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.